Objectives: The purpose of the present paper is to review available information on the treatment of peri-implant mucositis and peri-implantitis.
At the First European Workshop on Periodontology, peri-implantitis was defined as an inflammatory process affecting the tissues around an osseointegrated implant in function, resulting in loss of supporting bone. Peri-implant mucositis was defined as reversible inflammatory changes of the peri-implant soft tissues without any bone loss (Albrektsson & Isidor 1994) .
The prevalence of peri-implant mucositis has been reported in the range of 8-44% , Spörlein & Stein 1987 , Smedberg et al. 1993 , van Steenberghe et al. 1993 , Bengazi et al. 1996 , Jepsen et al. 1996 , Behneke et al. 1997a , while frequency of peri-implantitis has been reported in the range of 1-19% (Spörlein & Stein 1987 , van Steenberghe et al. 1990 , 1993 , Weber et al. 1992 , Smedberg et al. 1993 , Lekholm et al. 1999 . The wide ranges for the frequencies seem to be due to differences in defining the two entities, at least in part. The frequency of peri-implantitis is most likely related to the number of years implants have been worn. Since dental implant treatment was introduced comparatively recently, the numbers will probably increase over the years.
Interest in methods for the treatment of peri-implantitis emerged during the 1990s. An increasing number of animal studies and reports on clinical outcomes in patients have been published. The purpose of the present literature review is to present available information on treatment of mucositis and peri-implantitis. The review includes the following items:
Animal studies Human studies For each of the above issues, reports identified in the literature (up to January 2002) have been arranged in separate tables (Tables 1-9) . The text provides itemized comments and some concluding remarks for each topic. A few final remarks and some suggestions for further studies complete the review.
In preparation for this review, a literature search (Pub Med), using ''periimplant infections'', ''peri-implant infections'', ''periimplantitis'', ''peri-implantitis'', ''periimplant mucositis'', ''peri-implant mucositis'', ''treatment periimplant infections'', ''treatment peri-implant infections'', ''treatment periimplantitis'', ''treatment peri-implantitis'', ''treatment periim- Comments on animal studies (Table 1) Animal studies: ligature-induced peri-implantitis
All animal studies on the treatment of experimental peri-implantitis, except one, utilized ligature-induced lesions:
Mandibular premolar/first molar areas in dogs were most often used.
There are studies to indicate that spontaneous formation of new bone does not occur after ligature removal (Marinello et al. 1995 . Although generally not reported, it appears that the ligature-induced defects are primarily circular and funnel-like (as seen from available clinical illustrations). The intraosseous defect depths were reported in a few studies only, but seem to range from averages of 2.0-3.5 mm , Singh et al. 1993 , Hanisch et al. 1997 . Defect width was recorded in one study only and averaged 1.5 mm ).
Animal studies: methods for evaluation of results
Although some studies were limited to measurements of the amount of new bone at a surgical re-entry (Jovanovic et al. 1993 , Singh et al. 1993 , Machado et al. 1999 , Nociti et al. 2001 , biopsy with histological examination was most often used to assess the amount of new bone and the degree of re-osseointegration. The methods for these determinations varied among the studies.
The following remarks can be made for the histological assessments of the amount of new bone:
A few studies provided verbal descriptions only, without any measurements (Günay et al. 1991 . What seems to be the most adequate method -measurement of the height For abbrevations see Table 1 . § Implant type as described by the authors.
n Statistically significant reductions compared to placebo. (Grunder et al. 1993 , Hall et al. 1999 , Persson et al. 2001a . Other studies measured the height of new bone to the most coronal bone crest (including bone separated from implant by a connective tissue capsule) (Hanisch et al. 1997 , Hürzeler et al. 1997 , Wetzel et al. 1999 ).
The following remarks can be made for the measurements of the degree of re-osseointegration:
It was sometimes recorded as the height of new bone adjacent to the implant (not separated by a connective tissue capsule) (Singh et al. 1993 , Hürzeler et al. 1997 , Hall et al. 1999 , Persson et al. 1999 , 2001b , Wetzel et al. 1999 ). This measurement equals that used by others for new bone formation (see above). It was sometimes recorded as % reosseointegration of the newly formed bone, i.e. the proportion of the newly formed bone that shows direct juxtaposition to the implant (marrow spaces excluded) (Hanisch et al. 1997 , Machado et al. 2000 , Persson et al. 2001a ).
It should be realized that formation of new bone in the apical part of the defects may have occurred against an implant surface that was not contaminated before treatment. A connective tissue 'cuff' is present between the apical part of the epithelialized periimplant lesion and the bone . However, the magnitude of new bone formation achieved in some of the studies -illustrated by cases of more or less complete resolution of the peri-implantitis defect -suggests that new bone can form in direct contact with a previously contaminated implant surface (re-osseointegration) (e.g. Jovanovic et al. 1993 , Hürzeler et al. 1997 ).
Animal studies: methods for debridement/detoxification of implant surface
The following remarks emanate from the results of available studies:
Mechanical cleaning using abrasive air-powder was used in several studies and appeared to provide adequate detoxification to allow for new Leung et al. (2001) bone formation in direct contact with the implant surface (e.g. Jovanovic et al. 1993 , Hürzeler et al. 1997 .
Cleaning with delmopinol was used in a couple of studies. Results raise doubts on the effectiveness . Irrigation with chlorhexidine was used in one study. Results cast doubts for effectiveness of this method (Wetzel et al. 1999 ).
The results of Persson et al. (1999 Persson et al. ( , 2001a ) not only questions if mechanical debridement with cotton pellets 1 saline is adequate, but also questions the use of rotating brush 1 pumice. However, more recent results by Persson et al. (2001b) suggest that cotton pellets 1 saline may be adequate for the treatment of rough implant surfaces. They speculated that re-osseointegration may not only be a matter of detoxification of the implant surface but also a matter of ability of the treated surface to provide adhesion and stability of the coagulum during the initial healing phase.
Animal studies: use of systemic antibiotics
Postoperative systemic antibiotics were used in the majority of the available studies. Metronidazole or amoxicillin 1 metronidazole was the most common choice. The value of systemic antibiotics cannot be assessed, since there are no studies comparing results versus their nonuse.
Animal studies: surgical treatment
Various surgical techniques were evaluated:
The majority of studies utilized primary flap closure and postoperative submerging of the treated defect/ implant. Only two studies compared submerged versus nonsubmerged techniques (Grunder et al. 1993 , Singh et al. 1993 ). The results of these studies fail to present any convincing evidence that a submerged technique is superior. It can be speculated that most authors assumed that submerging is beneficial, since this was most often the choice for wound closure. The use of bone grafts/bone graft substitutes to supplement the surgical curettage was evaluated in five studies. Findings by Hürzeler et al. (1997) , Hall et al. (1999) , Machado et al. (2000) , and possibly also by Günay et al. (1991) and Nociti et al. (2001) indicate some adjunctive effects. Use of bioactive glass to supplement the surgical debridement was evaluated in one study using surgically created three-wall defects (Hall et al. 1999) . No adjunctive effects were observed. e-PTFE barrier membranes to supplement the surgical curettage was evaluated in eight studies with submerged closure (Günay et al. 1991 , Grunder et al. 1993 , Singh et al. 1993 , Hürzeler et al. 1997 , Wetzel et al. 1999 , Machado et al. 2000 , Nociti et al. 2001 ). Five of these eight studies found an advantage to the use of e-PTFE membranes, in spite of the fact that postoperative exposure of the membranes seems to be a frequent complication. Biodegradable collagen membranes were used in one study and gave comparable bone fill to e-PTFE membranes as assessed at surgical re-entry (Nociti et al. 2001 ). The combination of bone grafts/bone graft substitutes and e-PTFE barrier membranes to supplement the surgical curettage was evaluated in three studies with submerged wound closure. Hürzeler et al. (1997) found improved results with the combined treatment compared to the use of bone grafts/bone graft substitutes or e-PTFE membranes alone, while Machado et al. (2000) and Nociti et al. (2001) found no difference.
Animal studies: concluding remarks
Results of animal studies on the treatment of ligature-induced peri-implantitis indicate that:
Predictable and complete resolution of the experimental peri-implantitis defects has not been accomplished. Use of abrasive air-powder may be the only method of those used to date that provides sufficient implant detoxification to allow the formation of new bone in direct contact with the implant surface.
Use of e-PTFE membranes with a submerged wound closure may It should be realized that the above concluding remarks have been made based upon a limited number of studies, which were difficult to interpret collectively due to methodological differences. For example, methods for the assessment of new bone formation and re-osseointegration varied. In addition, the results of individual studies were often difficult to evaluate, in some instances due to lack of quantitative data, and in others due to a limited number of experimental animals.
Comments on human studies
Human studies. Treatment of peri-implant mucositis (Table 2) Two controlled studies, both of them using 3 months of observation, were identified on treatment of inflammation of the peri-implant mucosa in cases without concomitant loss of peri-implant bone support:
An antiseptic mouthrinse (Listerine) was found to reduce the levels of plaque and inflammation as compared to a placebo rinse (Ciancio et al. 1995) . Little effect was noted from submucosal placement of tetracycline fibers (Schenk et al. 1997 ). However, plaque scores were persistently high in this study.
Thus, at this point in time, there is scarce information on suitable methods to treat peri-implant mucositis.
Human studies. Treatment of peri-implantitis using closed debridement (Table 3) Six case reports that employed closed debridement, and with observation intervals from 3 to 12 months, were identified on treatment of peri-implantitis (lesions with radiographic bone loss).
The available case reports used different combinations of occlusal adjustment, mechanical debridement, topical antimicrobials and systemic antibiotics. Short-term mean improvements in the soft tissues were reported in all six studies. The relative value of the individual treatment components cannot be assessed. Evidence of some radiographic bone fill was reported in five of the six studies. Mombelli et al. (2001) treated 30 lesions with mechanical debridement and placement of tetracycline fibers. Mean improvements in clinical parameters resulted, which were sustained over a 12-month observation period. Microbiological parameters also improved initially, but rebounded during the observation interval. Two failures showing ''persisting active peri-implantitis with pus formation'' were reported. Buchmann et al. (1996 Buchmann et al. ( , 1997 initially treated 20 lesions with closed debridement including the use of topical antimicrobial irrigation and systemic antibiotics. For six of the lesions, additional surgical procedures were performed. It would seem that these six cases were considered failures.
From the case series considered, it may be concluded that a closed debridement approach aimed at reducing the submucosal infection can improve the conditions of peri-implantitis lesions, at least on a short-term basis. However, failures have been reported.
Human studies. Treatment of peri-implantitis using open debridement (Table 4) Only one case report including one implant was identified on treatment of peri-implantitis using open, surgical debridement. Osteoplasty and apical flap positioning were used and soft tissue healing was reported.
Human studies. Treatment of peri-implantitis using bone grafts and bone graft substitutes (Table 5) Eight case reports were identified on treatment of peri-implantitis using bone grafts or bone graft substitutes. Six of these eight reports included only a few cases.
Most of the treated lesions were located in the mandible. Autogenous bone, demineralized freeze-dried allogenic bone, bovine anorganic bone and hydroxyapatite For abbrevations see Table 1 . § Implant type as described by the authors. were used. All studies used a nonsubmerged approach, i.e. wound closure with repositioned surgical flaps. The reports by Behneke et al. (1997a Behneke et al. ( ,b, 2000 include multiple cases treated with autogenous bone grafts and with observation intervals extending up to 3 years. Notable reductions of probing depths coupled with significant radiographic bone fill were reported. Out of the 25 consecutive lesions treated by Behneke et al. (2000) , treatment failure and graft removal were reported for two lesions. Another four lesions showed flap dehiscences within 2-3 weeks after grafting. The use of grafts of demineralized freeze-dried allogenic bone, bovine anorganic bone or hydroxyapatite may also lead to improved clinical conditions. However, there was a limited number of cases for each of the different graft materials. Failures were also reported following these procedures. Methods for implant debridement/ detoxification varied among the studies, as did the use of systemic antibiotics.
From the case reports available, it can be concluded that treatment of periimplantitis lesions with autogenous bone grafts/bone graft substitutes may lead to fill of the defects and improved soft tissue conditions. Failures have been reported.
One comparative study was presented evaluating the use of autogenous bone grafts with and without the application of barrier membranes (Khoury & Buchmann 2001) . This study is reviewed under the heading ''Treatment of periimplantitis using the combination of grafts and barrier membranes'' (Table 7) .
Human studies. Treatment of peri-implantitis using barrier membranes (Table 6) Seven case reports were identified on treatment of peri-implantitis with barrier membranes. Five of these seven reports included only isolated cases.
e-PTFE membranes were used in all instances except in one case employing a collagen membrane. Only one study used a submerged approach, i.e. primary closure of the surgical flaps. The remaining studies used a nonsubmerged approach.
Methods for implant debridement/ detoxification varied among the studies. Systemic antibiotics were utilized in all of the reports. Early membrane exposure was a common complication and may lead to treatment failure. Aughtun et al. (1992) reported the treatment outcome of 15 lesions in 12 patients. On average, some radiographic bone loss was observed using orthopantomograms. Only minor improvements of soft tissue conditions were found. Membrane exposures occurred after 4-6 weeks in 13 of the 15 treated sites. The remaining studies reported bone fill of the defects and improved soft tissue conditions (when recorded).
It can be concluded that treatment of peri-implantitis lesions with e-PTFE membranes may lead to bone fill of the defects and improved soft tissue conditions.
Human studies. Treatment of peri-implantitis using the combination of grafts and barrier membranes (Table 7) Ten case reports were identified on treatment of peri-implantitis using a combination of grafts and barrier membranes. Eight of these 10 reports included only a few cases.
Most of the treated lesions were located in the mandible. Grafts of autogenous bone, demineralized freeze-dried allogenic bone and hydroxyapatite were used. e-PTFE membranes were used in the majority of instances. One case employed a polylactic acid membrane, one case a lamellar bone sheet membrane, and one case a calcium sulfate membrane. Early membrane exposure was a common complication. The majority of studies used a submerged approach. However, a successful outcome was also observed following a non-submerged approach. Methods for implant debridement/ detoxification varied among the studies. Systemic antibiotics were utilized in six out of the 10 reports. Mellonig & Triplett (1993) treated 12 lesions with grafts of demineralized freeze-dried allogenic bone and grafting and/or barrier membranes (no specific recommendations) Flemmig (1994) Peri-implant mucositis oral hygiene1occlusal evaluation/adjustment1supra-and submucosal scaling1topical antimicrobials (tetracycline fibers or CHX irrigation) if no resolution: systemic antibiotics (after sensitivity test)1topical CHX irrigation1surgical elimination of deep pockets/hyperplastic mucosa Peri-implantitis as for mucositis above, but combined with systemic antibiotics (without sensitivity test) if no resolution: as for mucositis above regenerative surgery (unspecified) only after successful resolution of infection Kao et al. (1997) Peri-implant mucositis oral hygiene1occlusal evaluation/adjustment1local debridement1topical CHX (2 Â daily)
Peri-implantitis
As for mucositis above1open debridement1implant smoothing and detoxification (citric acid)1osseous contouring1apically positioned flap1postoperative antibiotics (clindamycin or amoxicillin1metronidazole for 7 days). regenerative surgery not used Lang et al. (1997) Peri-implant mucositis/peri-implantitis ''cumulative interceptive supportive therapy'' PD o4 mm: oral hygiene1debridement (soft scalers1rubber cup1paste) (Step A) PD: 4-5 mm:
Step A1antiseptic therapy (CHX rinse or topical CHX gel daily) (Step A1B) PDX6 mm:
Step A1B1tetracycline fibers for 10 days1systemic antibiotics for 10 days (ornidazole or metronidazole or amoxicillin1metronidazole) (Step A1B1C) surgery only after successful elimination of infection. regenerative approach (barrier membrane, nonsubmerged) or resective approach (osteoplasty1apically positioned flap) ''depending on esthetic considerations and morphological characteristics of the lesion'' no specific methods recommended for implant smoothing and detoxification e-PTFE membranes and reported ''complete success -coverage of all threads'' in 10 lesions -and ''partial success -maximum two threads or 2 mm left uncovered'' in the remaining 2 lesions. Haas et al. (2000) treated 24 lesions with grafts of autogenous bone and e-PTFE membranes and reported an average radiographic bone fill of 2.0 mm. Two lesions showed 0.5 mm bone loss. Two other implants with defects reaching the ''implant basket'', in spite of some initial radiographic bone fill, were later removed. Premature membrane exposure was encountered for all implant sites. Data analyses indicated that the longer the membranes remained covered, the more bone fill was obtained. However, the analyses also suggested that the longer an exposed membrane was left in place, the smaller the resultant bone gain.
From the case reports available, it can be concluded that treatment of periimplantitis lesions with the combination of grafts and e-PTFE membranes may lead to bone fill and improved soft tissue conditions. Comparison of the overall outcomes of cases treated with grafts alone, e-PTFE membranes alone, or their combination -to the extent that such a comparison can be done -does not indicate a superiority to the combination.
In addition to the case reports reviewed above, a comparative study was recently published evaluating the use of autogenous bone grafts with and without the placement of e-PTFE membranes or collagen membranes employing a submerged technique (Khoury & Buchmann 2001) . Average bone fills amounting to 2-3 mm were obtained, with no significant differences between the treatment groups. Membrane exposures and other complications occurred for around 60% of the implants receiving e-PTFE or collagen membranes. No complications were observed following bone grafts alone. The results of this study -seemingly the only comparative study available to date on treatment of peri-implantitis -thus support the impression from the case reports reviewed above indicating that placement of barrier membranes in addition to bone grafting does not provide any adjunctive effects.
Human studies. Maintenance treatment (Table 8) One study evaluating diode laser decontamination as and adjunct to ''conventional treatment'' over 5 years with biannual recalls was identified. The authors reported a lower relapse rate following adjunctive laser use as compared to the ''conventional treatment'' (unspecified). Unfortunately, this study is difficult to evaluate due to the nature of the data presentation.
Comments on proposed strategies for treatment of mucositis/peri-implantitis ( Table 9) Five reports that presented strategies for the treatment of mucositis/peri-implantitis are reviewed. The following comments can be made:
There is a consensus that proper oral hygiene should be established, and that occlusal forces should be evaluated and corrected by occlusal adjustment when deemed traumatic. Supra-and submucosal mechanical debridement and topical antimicrobial treatment should be part of the initial therapy. Various topical antimicrobial treatments are recommended (e.g. patient administered chlorhexidine application; professional irrigation with chlorhexidine, hydrogen peroxide, stannous fluoride or tetracycline solutions; application of tetracycline fibers). The use of systemic antibiotics as part of the initial therapy is recommended in four of the five treatment strategies. In cases with horizontal bone loss or with wide/shallow intraosseous defects showing inadequate resolution after initial therapy, open debridement combined with osseous recontouring and apical flap positioning is suggested in four of the five treatment strategies. The remaining author recommend ''surgical elimination of deep pockets/hyperplastic mucosa'' without providing further details (Flemmig 1994) . As part of the apically positioned flap surgery, all of the recommendations include mechanical implant surface smoothing and chemical surface detoxification. The recommended detoxification agent varies (e.g. abrasive sodium carbonate air-powder, citric acid or an antimicrobial agent).
Regenerative surgery is proposed by Kwan & Zablotsky (1991) for intrabony two-and three-wall defects, circumferential moat defects and dehiscence defects, and by Jovanovic (1993) for intrabony defects X3 mm deep. Flemmig (1994) and Lang et al. (1997) also recommend regenerative surgery without reference to defect morphology. Kao et al. (1997) advise against regenerative surgery. Flemmig (1994) does not mention any preferred regenerative approach. Lang et al. (1997) suggest the use of barrier membrane (nonsubmerged). Kwan & Zablotsky (1991) and Jovanovic (1993) propose grafting or barrier membrane, or a combination of both procedures (submerged if possible), without providing any specific recommendations as to the selection of graft material and barrier membrane. The use of postoperative systemic antibiotics following regenerative procedures is proposed by Jovanovic (1993) , but is not commented upon by the other authors.
Final remarks
The results of animal studies on the treatment of ligature-induced peri-implantitis indicate that repair of periimplant defects is possible, including the formation of new bone in direct contact with the implant surface (reosseointegration). This is an essential piece of information. Apart from this, a critical analysis does not suggest that animal research on peri-implantitis has been very fruitful as yet. However, animal studies may be useful for further attempts at answering biological questions, e.g. suitable methods for detoxification of implant surfaces.
Two controlled studies on the treatment of peri-implant mucositis in humans were identified in the literature. Studies on the treatment of peri-implantitis, with one exception, were all case reports and most of these were short-term and included a few cases only.
Case reports can be useful to indicate the potential of different therapies. Thus, the available reports demonstrate that efforts to reduce the submucosal infection may result in improvements of peri-implant lesions, at least on a shortterm basis. The case reports also show that regenerative procedures in intrabony peri-implant defects may result in the formation of new bone. A 3-year follow-up of 10 out of 25 implants treated with autogenous bone suggests that the stability of initial improvements can be maintained (Behneke et al. 2000) . The stability of average treatment results over 3 years following autogenous bone grafting with or without placement of barrier membranes was also reported by Khoury & Buchmann (2001) , treating a total of 41 implants.
Proposed strategies for the treatment of peri-implantitis identified in the literature were found to have many common recommendations. Due to the lack of controlled or comparative research, these recommendations, however, must be recognized as empirical.
Several uncertainties remain about the treatment of peri-implantitis. The relative importance of mechanical debridement, use of topical antimicrobials and systemic antibiotics during closed debridement is not known. The benefits of open debridement and pocket reduction are uncertain. Methods for adequate detoxification of various types of implant surfaces need to be established. The most efficient regenerative procedure has not been identified. There seems to be no report in humans in which histologic examination addresses the issue of the potential for re-osseointegration to a previously contaminated implant surface. There is limited knowledge as to what extent initial improvements are sustained over the long-term and if further loss of implant-supporting bone can be prevented.
It may not be realistic to expect the appearance of many comparative studies on methods for the treatment of peri-implantitis in the literature in the near future. Difficulties in recruiting sufficient numbers of subjects with comparable peri-implant lesions may hamper attempts at conducting such studies (as illustrated by the Khoury & Buchmann study, the only comparative study available). In lieu of this, the long-term monitoring of consecutively treated cases with a given approach should be encouraged, since this may assist us in establishing the predictability, magnitude and stability of improvements that can be achieved. In such studies, systemic and local factors that potentially may affect the outcome of treatment should be carefully recorded and evaluated. This may result in elucidation of the factors affecting results for particular treatments. 
Ré sumé
Traitement des infections pe´ri-implantaires: une revue de litte´rature Cet article se propose de faire par une revue de la littérature la somme des informations disponibles sur le traitement des mucosites periimplantaires et des peri-implantites. Les résul-tats en recherche animale et des études humaines sont présentés. Des stratégies proposées pour le traitement de la peri-implantite, présentées dans la littérature, sont également incluses. La plupart des informations accessibles à l'heure actuelle proviennent de rapports de cas. Ces rapports apportent la preuve que les efforts pour réduire l'infection de la sousmuqueuse pourraient entraîner des améliora-tions sur le court terme de la lésion periimplantaire. Ils indiquent aussi que les protocoles de régénération des lésions intra-osseuses peuvent entraîner la formation de nouvel os. Cependant, plusieurs incertitudes subsistent sur le traitement des peri-implantites. Des suivis convenablement menés sur le long terme de cas traités consécutivement sembleraient être une approche réaliste pour l'accumulation de plus d'information. Cela devrait nous aider à établir la prévisibilité, l'importance, et la stabilité des améliorations qui peuvent être obtenues.
